Clindamycin is a semisynthetic, broad-spectrum antibiotic derived from lincomycin. It inhibits bacterial protein synthesis by causing premature dissociation of peptidyl-tRNA from the ribosome. This mechanism is utilized in research applications for studying bacterial pathogenesis and antibiotic action in both in vitro and in vivo models.